Updated guidance on vascular cognitive impairment emphasizes executive function and processing speed, endorses brief, ...

MOXO360™ represents a breakthrough in how attention, executive function, and learning abilities are measured and understood. Unlike traditional tests that focus solely on symptom-based diagnostics, ...

A new randomized, double-blind, sham-controlled clinical trial reports that a non-invasive, home-based light therapy produced measurable improvements in objective cognitive performance in adults under ...

Cannabis use may impair the ability of people with multiple sclerosis to accurately self-assess their cognitive performance.

BrainAurora Medical Technology Limited ( ($HK:6681) ) has provided an update. BrainAurora Medical Technology Limited, through its indirect wholly ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- ...